Announcements Trials
Browse Landscape

Phase

Phase 2 46Phase 1 19Phase 1/2 13Phase NA 10Phase EARLY_PHASE1 7Phase 3 5Phase 4 2Phase 2/3 1

Status

Completed 46Unknown 8Recruiting 8Terminated 6Active not recruiting 5Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 5Gynecologic 1Dermatologic 1

Conditions

Breast Neoplasms 109Carcinoma, Non-Small-Cell Lung 96Prostatic Neoplasms 60Multiple Myeloma 46Neoplasms 38Neoplasm Metastasis 33Ovarian Neoplasms 26Urinary Bladder Neoplasms 24Melanoma 24Lung Neoplasms 22Recurrence 21Parkinson Disease 4, Autosomal Dominant Lewy Body 21Leukemia, Lymphocytic, Chronic, B-Cell 21Colorectal Neoplasms 21Carcinoma, Renal Cell 20Leukemia, Myeloid, Acute 17Carcinoma, Hepatocellular 17Triple Negative Breast Neoplasms 16Lymphoma, Non-Hodgkin 16Stomach Neoplasms 15Nasopharyngeal Carcinoma 15Lymphoma 14Squamous Cell Carcinoma of Head and Neck 13Small Cell Lung Carcinoma 13Fallopian Tube Neoplasms 12Colonic Neoplasms 12Carcinoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Large B-Cell, Diffuse 11Lymphoma, Follicular 11

Interventions

pazopanib 1eribulin 1Zoledronic Acid 1Trabectedin 1Methotrexate 1Imatinib Mesylate 1Ifosfamide 1Etoposide 1Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Active not recruiting × Sarcoma × Clear all
NCT01223248 2025-11-04

Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy

Memorial Sloan Kettering Cancer Center

Phase 3 Active not recruiting
220 enrolled
DermatologicGynecologicSarcoma

Melanoma, Ovarian Neoplasms, Sarcoma, Pyloric Stenosis, Hypertrophic

NCT06263231 2025-07-29

INVINCIBLE-3

Intensity Therapeutics, Inc.

Phase 3 Active not recruiting
333 enrolled
Sarcoma

Sarcoma

NCT00470223 2025-06-08

OS2006

UNICANCER

Phase 3 Active not recruiting
318 enrolled
Sarcoma

Sarcoma, Osteosarcoma

NCT02413736 2025-03-12

Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST

Helsinki University Central Hospital

Phase 3 Active not recruiting
255 enrolled
Sarcoma

Sarcoma

NCT02565498 2024-02-20

Preoperative vs Postoperative IMRT for Extremity/Truncal STS

Mount Sinai Hospital, Canada

Phase 3 Active not recruiting
210 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡